CUPR Cuprina Holdings (Cayman) Limited - Ordinary shares
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Jul 1, 2026
$2.42
· of 52w range
· above low
· to high
$0.2252w low
$14.8052w high
P/E
-0.0
EPS
$-22.83
Revenue
$49.9K
your badges
52W Range
$0–$15
Analyst Rating
·
Price Target
·
P/E
-0.0
ROE
-1569.0%
Net Profit Margin
-9366.8%
Your badge strip is empty — pin a metric anywhere on this page.
CUPR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$2.42
P/E
-0.0
EPS
$-22.83
Revenue
$49.9K
ROE
-1569.0%
Debt/Equity
0.0
52W Range
$0–$15
CUPR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| May 27, 2026 | 1-for-8 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$49.9K2022-12-31 → 2025-12-31
EPS$-22.832022-12-31 → 2025-12-31
Free Cash Flow$-9M2024-12-31 → 2025-12-31
Net margin-9366.8%2024-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | CUPR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -0.0 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | CUPR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin | -1.3% | · | · | · | |
| Operating Margin | -9680.2% | · | · | · | |
| EBITDA Margin | -9680.2% | · | · | · | |
| Pretax Margin | -9239.8% | · | · | · | |
| Net Profit Margin | -9366.8% | · | · | · | |
| ROA | -91.2% | · | · | · | |
| ROE | -1569.0% | · | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | CUPR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity | 0.0 | · | · | · | |
| Current Ratio | 2.4 | · | · | · | |
| Quick Ratio | 1.0 | · | · | · | |
| Long-Term Debt / Equity | 0.0 | · | · | · | |
| Interest Coverage | -328.0 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | CUPR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | |
| Receivables Turnover | 2.2 | · | · | · | |
| Revenue / Employee | ≈$5.0K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $49.9K | $48.3K | $100.8K | |
| Cost of Revenue | $50.5K | $51.3K | $64.2K | |
| Gross Profit | $-645 | $-3.0K | $36.6K | |
| R&D Expense | $226.9K | $241.4K | $167.7K | |
| SG&A Expense | $5M | $1M | $937.2K | |
| Operating Expenses | $5M | $2M | $1M | |
| Operating Income | $-5M | $-2M | $-1M | |
| Interest Expense | $14.7K | $1.8K | $727 | |
| Other Non-op | $219.7K | $136.7K | $-17.4K | |
| Pretax Income | $-5M | $-2M | $-1M | |
| Net Income | $-5M | $-2M | $-1M | |
| EPS (Basic) | $-22.83 | $-8.68 | $-6.22 | |
| EPS (Diluted) | $-22.83 | $-8.68 | $-6.22 | |
| Shares (Basic) | 20,471,507 | 18,000,000 | 18,000,000 | |
| Shares (Diluted) | 20,471,507 | 18,000,000 | 18,000,000 | |
| EBITDA | $-5M | $-2M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $3M | $116.5K | $35.3K | |
| Receivables | $18.2K | $26.4K | $50.8K | |
| Inventory | · | $1.7K | $7.7K | |
| Prepaid Expense | $4M | $79.7K | $72.6K | |
| Other Current Assets | $4M | $146.2K | $156.8K | |
| Current Assets | $7M | $2M | $1M | |
| PP&E (Net) | $77.5K | $58.1K | $78.4K | |
| PP&E (Gross) | $263.2K | $207.3K | $185.4K | |
| Accum. Depreciation | $185.7K | $149.2K | $107.0K | |
| Other Non-current Assets | $779.2K | · | · | |
| Total Assets | $9M | $2M | $2M | |
| Accounts Payable | $1.2K | · | · | |
| Accrued Liabilities | $30.6K | $324.0K | $375.4K | |
| Current Liabilities | $3M | $6M | $4M | |
| Capital Leases | $207.6K | · | $35.8K | |
| Total Liabilities | $3M | $6M | $4M | |
| Long-term Debt | $164.9K | $219.0K | · | |
| Total Debt | $164.9K | $219.0K | · | |
| Paid-in Capital | $14M | $78.7K | $78.7K | |
| Retained Earnings | $-9M | $-5M | $-3M | |
| AOCI | $348.5K | $-1.6K | $309 | |
| Stockholders' Equity | $5M | $-4M | $-3M | |
| Liabilities + Equity | $9M | $2M | $2M |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $36.5K | $42.2K | $35.1K | |
| Operating Cash Flow | $-9M | $-1M | $-895.0K | |
| CapEx | $58.2K | $21.9K | $68.0K | |
| Investing Cash Flow | $-58.2K | $-21.9K | $-68.0K | |
| Stock Issued | $18M | · | · | |
| Net Stock Activity | $18M | · | · | |
| Financing Cash Flow | $12M | $1M | $433.1K | |
| Free Cash Flow | $-9M | $-1M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Gross Margin | -1.3% | -6.3% | · | |
| Operating Margin | -9680.2% | -3404.8% | · | |
| Net Margin | -9366.8% | -3229.5% | · | |
| Pretax Margin | -9239.8% | -3122.1% | · | |
| EBITDA Margin | -9680.2% | -3404.8% | · | |
| ROA | -91.2% | -93.7% | · | |
| ROE | -1569.0% | 41.9% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 2.4 | 0.3 | · | |
| Quick Ratio | 1.0 | 0.0 | · | |
| Debt / Equity | 0.0 | -0.0 | · | |
| LT Debt / Equity | 0.0 | -0.0 | · | |
| Interest Coverage | -328.0 | -922.7 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | |
| Inventory Turnover | · | 10.9 | · | |
| Receivables Turnover | 2.2 | 1.3 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue / Share | $0.00 | $0.00 | · | |
| Cash Flow / Share | $-0.45 | $-0.07 | · | |
| EPS (TTM) | $-22.83 | $-8.68 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $49.9K | $48.3K | · | |
| Net Income TTM | $-5M | $-2M | · | |
| P/E | -0.0 | · | · | |
| Earnings Yield | -5707.5% | · | · |
Per Share
| Metric | Trend | Q4 2025 |
|---|---|---|
| EPS (TTM) | $-22.83 |
Valuation (TTM)
| Metric | Trend | Q4 2025 |
|---|---|---|
| Revenue TTM | $49.9K | |
| Net Income TTM | $-5M | |
| P/E | -0.0 | |
| Earnings Yield | -5707.5% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | $49.9K | $48.3K | $100.8K | $56.6K |
| Gross Margin % | -1.3% | -6.3% | · | · |
| Operating Margin % | -9680.2% | -3404.8% | · | · |
| Net Income | $-5M | $-2M | $-1M | $-1M |
| Diluted EPS | $-22.83 | $-8.68 | $-6.22 | $-6.08 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Debt / Equity | 0.0 | -0.0 | · | · |
| Current Ratio | 2.4 | 0.3 | · | · |
| Quick Ratio | 1.0 | 0.0 | · | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $-9M | $-1M | · | · |
Institutional owners (13F)
Institutional activity — Q1 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 2 (0 vs prior Q) | 1 (-1 vs prior Q) | 0 (0 vs prior Q) | 2 (+1 vs prior Q) | +41K |
Compared to Q4 2025. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F/A filed Jul 1, 2026